Global Aurora Kinase B Market Research Report 2019-2025

Description

In 2019, the market size of Aurora Kinase B is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Aurora Kinase B.

This report studies the global market size of Aurora Kinase B, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Aurora Kinase B sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca Plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc

Market Segment by Product Type
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others

Market Segment by Application
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Aurora Kinase B status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Aurora Kinase B manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Aurora Kinase B are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Aurora Kinase B Market Size Growth Rate by Type (2019-2025)
1.3.2 AZD-2811
1.3.3 CS-2164
1.3.4 Danusertib
1.3.5 Ilorasertib
1.3.6 NMI-900
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Aurora Kinase B Market Share by Application (2019-2025)
1.4.2 Anaplastic Large Cell Lymphoma
1.4.3 Kidney Cancer
1.4.4 Lung Cancer
1.4.5 Prostate Cancer
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Aurora Kinase B Market Size
2.1.1 Global Aurora Kinase B Revenue 2014-2025
2.1.2 Global Aurora Kinase B Sales 2014-2025
2.2 Aurora Kinase B Growth Rate by Regions
2.2.1 Global Aurora Kinase B Sales by Regions 2014-2019
2.2.2 Global Aurora Kinase B Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Aurora Kinase B Sales by Manufacturers
3.1.1 Aurora Kinase B Sales by Manufacturers 2014-2019
3.1.2 Aurora Kinase B Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Aurora Kinase B Revenue by Manufacturers (2014-2019)
3.2.2 Aurora Kinase B Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Aurora Kinase B Market Concentration Ratio (CR5 and HHI)
3.3 Aurora Kinase B Price by Manufacturers
3.4 Key Manufacturers Aurora Kinase B Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Aurora Kinase B Market
3.6 Key Manufacturers Aurora Kinase B Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 AZD-2811 Sales and Revenue (2014-2019)
4.1.2 CS-2164 Sales and Revenue (2014-2019)
4.1.3 Danusertib Sales and Revenue (2014-2019)
4.1.4 Ilorasertib Sales and Revenue (2014-2019)
4.1.5 NMI-900 Sales and Revenue (2014-2019)
4.1.6 Others Sales and Revenue (2014-2019)
4.2 Global Aurora Kinase B Sales Market Share by Type
4.3 Global Aurora Kinase B Revenue Market Share by Type
4.4 Aurora Kinase B Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Aurora Kinase B Sales by Application

6 United States
6.1 United States Aurora Kinase B Breakdown Data by Company
6.2 United States Aurora Kinase B Breakdown Data by Type
6.3 United States Aurora Kinase B Breakdown Data by Application

7 European Union
7.1 European Union Aurora Kinase B Breakdown Data by Company
7.2 European Union Aurora Kinase B Breakdown Data by Type
7.3 European Union Aurora Kinase B Breakdown Data by Application

8 China
8.1 China Aurora Kinase B Breakdown Data by Company
8.2 China Aurora Kinase B Breakdown Data by Type
8.3 China Aurora Kinase B Breakdown Data by Application

9 Rest of World
9.1 Rest of World Aurora Kinase B Breakdown Data by Company
9.2 Rest of World Aurora Kinase B Breakdown Data by Type
9.3 Rest of World Aurora Kinase B Breakdown Data by Application
9.4 Rest of World Aurora Kinase B Breakdown Data by Countries
9.4.1 Rest of World Aurora Kinase B Sales by Countries
9.4.2 Rest of World Aurora Kinase B Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Aurora Kinase B
10.1.4 Aurora Kinase B Product Introduction
10.1.5 AbbVie Inc Recent Development
10.2 Advenchen Laboratories LLC
10.2.1 Advenchen Laboratories LLC Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Aurora Kinase B
10.2.4 Aurora Kinase B Product Introduction
10.2.5 Advenchen Laboratories LLC Recent Development
10.3 Aeterna Zentaris Inc
10.3.1 Aeterna Zentaris Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Aurora Kinase B
10.3.4 Aurora Kinase B Product Introduction
10.3.5 Aeterna Zentaris Inc Recent Development
10.4 Amgen Inc
10.4.1 Amgen Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Aurora Kinase B
10.4.4 Aurora Kinase B Product Introduction
10.4.5 Amgen Inc Recent Development
10.5 AstraZeneca Plc
10.5.1 AstraZeneca Plc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Aurora Kinase B
10.5.4 Aurora Kinase B Product Introduction
10.5.5 AstraZeneca Plc Recent Development
10.6 Chipscreen Biosciences Ltd
10.6.1 Chipscreen Biosciences Ltd Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Aurora Kinase B
10.6.4 Aurora Kinase B Product Introduction
10.6.5 Chipscreen Biosciences Ltd Recent Development
10.7 Cielo Therapeutics Inc
10.7.1 Cielo Therapeutics Inc Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Aurora Kinase B
10.7.4 Aurora Kinase B Product Introduction
10.7.5 Cielo Therapeutics Inc Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Aurora Kinase B
10.8.4 Aurora Kinase B Product Introduction
10.8.5 Sanofi Recent Development
10.9 Sareum Holdings Plc
10.9.1 Sareum Holdings Plc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Aurora Kinase B
10.9.4 Aurora Kinase B Product Introduction
10.9.5 Sareum Holdings Plc Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Aurora Kinase B Sales Channels
11.2.2 Aurora Kinase B Distributors
11.3 Aurora Kinase B Customers

12 Market Forecast
12.1 Global Aurora Kinase B Sales and Revenue Forecast 2019-2025
12.2 Global Aurora Kinase B Sales Forecast by Type
12.3 Global Aurora Kinase B Sales Forecast by Application
12.4 Aurora Kinase B Forecast by Regions
12.4.1 Global Aurora Kinase B Sales Forecast by Regions 2019-2025
12.4.2 Global Aurora Kinase B Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample